Of course here comes the offering . . . . can’t blame them for raising cash now with this news released . . . . .

My posture . . . . . holding on . . . . several reasons . . . . . one is when a stock really runs it may make sense to let it go for a while and see what it can do . . . . this is a “platform” kinda as opposed to a huge bet on one drug or even one disease . . . . though I have no idea exactly how this all works this Molecular Glue Degrader stuff is a novel and unique approach can be applied across a huge chunk of the sector . . . . who knows what they might have up their sleeve . . . . if it behaves I hold . . . .

Industry Group Medical Biomed/Biotech is intriguing . . . . obviously the market emphasized exactly that last few months . . . . but more of a structural change at the policy level trying to pull forward the new and exciting stuff . . . like with Defense and ProSec lighting a fire under the fat cat incumbents and activating more innovation . . . . different mindset and approach perhaps helpful in that it’s generally a lot of headline risk . . . . Up/Down Volume, Money Flow, Accumulation/Distribution will show us the actions taken by those that have been doing the heavy science/tech research all along . . . .

Note on the Weekly Chart above how all the Money Flow was oozing in well before this huge news update . . . . meaning the price you see on your screen today matters yes but let’s not forget how things got to where they are today in terms of Accumulation/Distribution and Money Flow and what that means about who and what already did big buying/selling PRIOR to today’s action (applies to all stocks) . . . . Translation: yet again the Money Flow, Up/Down Volume, and Accumulation/Distribution already showed us investors were moving into GLUE for several weeks . . . .